zotarolimus eluting stent
Showing 1 - 25 of 3,416
High Bleeding Risk, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Ciudad de México (Zotarolimus eluting
Recruiting
- High Bleeding Risk
- +2 more
- Zotarolimus eluting stent
- Sirolimus eluting stent
-
Ciudad de México, MexicoInstituto Nacional de Cardiología "Ignacio Chávez"
Feb 17, 2022
Coronary Artery Disease, Optical Coherence Tomography, Stent Trial in Yongin (Optical coherence tomography-guided percutaneous
Recruiting
- Coronary Artery Disease
- +2 more
- Optical coherence tomography-guided percutaneous coronary intervention
- Optical coherence tomography-guided Onyx expansion
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Apr 20, 2022
De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Xi'an (Lepu Paclitaxel coated balloon,
Recruiting
- De Novo Stenosis
- +2 more
- Lepu Paclitaxel coated balloon
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx
Recruiting
- Ischemic Heart Disease
- Clopidogrel monotherapy
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 13, 2022
Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™
Active, not recruiting
- Ischemic Heart Disease
- +4 more
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
-
Shenyang, Liaoning, China
- +1 more
Nov 2, 2022
Coronary Artery Disease Trial in Worldwide (Resolute Integrity Zotarolimus eluting stent, Xience Xpedition everolimus eluting
Completed
- Coronary Artery Disease
- Resolute Integrity Zotarolimus eluting stent
- +3 more
-
Atlanta, Georgia
- +9 more
Aug 16, 2022
Coronary Artery Disease, Myocardial Ischemia, Coronary Disease Trial in Korea, Republic of (Zotarolimus-Eluting Stent)
Active, not recruiting
- Coronary Artery Disease
- +2 more
- Zotarolimus-Eluting Stent
-
Changwon, Korea, Republic of
- +19 more
Jul 6, 2022
Multivessel Coronary Artery Disease Trial in Korea, Republic of (Percutaneous Coronary Intervention)
Completed
- Multivessel Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Kwangju, Chonnam, Korea, Republic of
- +8 more
Aug 31, 2021
High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) Trial in Ciudad de México (Drug
Terminated
- High Bleeding Risk
- +2 more
- Drug Eluting Balloon (DEB)
- Drug Eluting Stents (DES)
-
Ciudad de México, MexicoInstituto Nacional de Cardiologia "Ignacio Chávez"
Oct 19, 2021
Coronary Artery Disease Trial (MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS))
Not yet recruiting
- Coronary Artery Disease
- MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS)
- (no location specified)
Jun 10, 2022
RESOLUTE ONYX Post-Approval Study
Completed
- Coronary Artery Disease
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
-
Huntsville, Alabama
- +27 more
Oct 25, 2022
Coronary Artery Disease Trial in Worldwide (Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System)
Active, not recruiting
- Coronary Artery Disease
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
-
Huntsville, Alabama
- +24 more
Oct 10, 2022
Coronary Disease, Angina, Stable, Ischemia Trial in Spain (Percutaneous Coronary Intervention)
Completed
- Coronary Disease
- +4 more
- Percutaneous Coronary Intervention
-
Santiago De Compostela, A Coruña, Spain
- +14 more
Mar 8, 2021
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease Trial in Worldwide (Percutaneous Coronary Intervention)
Active, not recruiting
- Coronary Artery Disease
- +3 more
- Percutaneous Coronary Intervention
-
Antwerp, Belgium
- +35 more
Jul 29, 2022
Coronary Small Vessel Disease Trial in China (Cohort A: Dissolve™, Cohort A: Resolute™ Integrity, Cohort B: Dissolve™-2.00mm)
Active, not recruiting
- Coronary Small Vessel Disease
- Cohort A: Dissolve™
- +2 more
-
Beijing, China
- +14 more
Feb 16, 2022
Acute Coronary Syndrome, De Novo Stenosis Trial in Zunyi (ICI-guided JINS approach)
Recruiting
- Acute Coronary Syndrome
- De Novo Stenosis
- ICI-guided JINS approach
-
Zunyi, Guizhou, ChinaAffiliated Hospital of Zunyi Medical University
Aug 25, 2023
In-stent Restenosis Trial (Drug-eluting Coronary Spur Stent System)
Not yet recruiting
- In-stent Restenosis
- Drug-eluting Coronary Spur Stent System
- (no location specified)
Oct 31, 2023
Coronary Restenosis Trial in Hasselt, Massy (SELUTION SLR™ DEB, Control)
Recruiting
- Coronary Restenosis
- SELUTION SLR™ DEB
- Control
-
Hasselt, Belgium
- +1 more
Nov 10, 2022
Critical Limb Ischemia Trial (Drug Eluting Temporary Spur Stent System, Percutaneous Transluminal Balloon Angioplasty)
Not yet recruiting
- Critical Limb Ischemia
- Drug Eluting Temporary Spur Stent System
- Percutaneous Transluminal Balloon Angioplasty
- (no location specified)
Nov 8, 2023
Coronary Artery Disease Trial in United States (Device: Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System
Completed
- Coronary Artery Disease
- Device: Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System Treatment Followed by one-month DAPT
-
East Syracuse, New York
- +3 more
Oct 28, 2021
Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)
Recruiting
- Drug-eluting Stent
- Coronary Artery Disease
- Genoss® DES system, Genoss® Osfit system
-
Suwon, Korea, Republic ofAjou University Hospital
Sep 27, 2023
Coronary Stenosis, Coronary Artery Disease Trial (IoNIR Ridaforolimus-Eluting Coronary Stent System)
Not yet recruiting
- Coronary Stenosis
- Coronary Artery Disease
- IoNIR Ridaforolimus-Eluting Coronary Stent System
- (no location specified)
Oct 1, 2023
Restenosis Trial in Ostrava (paclitaxel-coated balloon catheter with Iopromide coating, drug eluting stent with everolimus,
Completed
- Restenosis
- paclitaxel-coated balloon catheter with Iopromide coating
- +2 more
-
Ostrava, CzechiaUniversity Hospital
Dec 6, 2022
Propel Drug-Eluting Sinus Stent Family
Recruiting
- Chronic Rhinosinusitis (Diagnosis)
- NA-Observational Registry
-
Wiesbaden, GermanyHelios Dr Horst Schmidt Kliniken
Jun 19, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Genoss DES stent)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Genoss DES stent
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Oct 16, 2023